Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study

Gynecologic Oncology

Volumn 120, Issue 2, 2011, Pages 280-283

  Eijsink, J J H ^a   Yang, N ^a   Lendvai, A ^a   Klip, H G ^a   Volders, H H ^a   Buikema, H J ^a   Van Hemel, B M ^a   Voll, M ^b   Bennink, H J T Coelingh ^b   Schuuring, E ^a   Wisman, G B A ^a   Van Der Zee, A G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Delphi Bioscience BV   (Netherlands)

Author keywords

Cervical; Cervical cancer; Lavage; Methylation markers; Neoplasia; Self sampling

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; C13ORF18 GENE; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; EPB41L3 GENE; FEASIBILITY STUDY; FEMALE; GENE; HUMAN; HUMAN CELL; JAM3 GENE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TERT GENE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINAL LAVAGE; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; FEASIBILITY STUDIES; FEMALE; HUMANS; NEOPLASM STAGING; PILOT PROJECTS; SELF-EXAMINATION; THERAPEUTIC IRRIGATION; UTERINE CERVICAL NEOPLASMS; VAGINA; VAGINAL SMEARS;

EID: 79251598419     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.10.029     Document Type: Article

References (20)

1. M. Arbyn, C. Bergeron, P. Klinkhamer, P. Martin-Hirsch, A.G. Siebers, and J. Bulten Liquid compared with conventional cervical cytology: a systematic review and meta-analysis Obstet Gynecol 111 1 2008 167 177
2. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J Clin Pathol 55 4 2002 244 265
3. N.W. Bulkmans, J. Berkhof, L. Rozendaal, F.J. van Kemenade, A.J. Boeke, and S. Bulk Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 9601 2007 1764 1772
4. M.H. Mayrand, E. Duarte-Franco, I. Rodrigues, S.D. Walter, J. Hanley, and A. Ferenczy Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 16 2007 1579 1588
5. S.L. Kulasingam, J.P. Hughes, N.B. Kiviat, C. Mao, N.S. Weiss, and J.M. Kuypers Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral JAMA 288 14 2002 1749 1757
6. S.B. Baylin, and J.E. Ohm Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6 2 2006 107 116
7. N. Wentzensen, M.E. Sherman, M. Schiffman, and S.S. Wang Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science Gynecol Oncol 112 2 2009 293 299
8. M.O. Hoque, M.S. Kim, K.L. Ostrow, J. Liu, G.B. Wisman, and H.L. Park Genome-wide promoter analysis uncovers portions of the cancer methylome Cancer Res 68 8 2008 2661 2670
9. N. Yang, J.J. Eijsink, A. Lendvai, H.H. Volders, H. Klip, and H.J. Buikema Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings Cancer Epidemiol Biomarkers Prev 18 11 2009 3000 3007
10. Eijsink1 JJH, Lendvai Á, Deregowski V, Klip HG, Verpooten G, Dehaspe L, de Bock GH, Hollema H, van Criekinge W, Schuuring E, van der Zee AGJ, Wisman GBA. A four gene methylation marker panel as triage test in hr-HPV positive patients. Submitted for publication.
11. A.B. Bos, M. Rebolj, J.D. Habbema, and B.M. van Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands Int J Cancer 119 10 2006 2372 2375
12. S. Bulk, O. Visser, L. Rozendaal, R.H. Verheijen, and C.J. Meijer Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women Int J Cancer 113 6 2005 1005 1009
13. J. Peto, C. Gilham, O. Fletcher, and F.E. Matthews The cervical cancer epidemic that screening has prevented in the UK Lancet 364 9430 2004 249 256
14. P.D. Sasieni, J. Cuzick, and E. Lynch-Farmery Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group Br J Cancer 73 8 1996 1001 1005
15. G.F. Sawaya, and D.A. Grimes New technologies in cervical cytology screening: a word of caution Obstet Gynecol 94 2 1999 307 310
16. M. Gok, D.A. Heideman, F.J. van Kemenade, J. Berkhof, L. Rozendaal, and J.W. Spruyt HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study BMJ 2010 340c1040
17. A.G. Bais, F.J. van Kemenade, J. Berkhof, R.H. Verheijen, P.J. Snijders, and F. Voorhorst Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs Int J Cancer 120 7 2007 1505 1510
18. A.A. Brink, C.J. Meijer, M.A. Wiegerinck, T.E. Nieboer, R.F. Kruitwagen, and K.F. van High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush J Clin Microbiol 44 7 2006 2518 2523
19. J.J. van Dongen, A.W. Langerak, M. Bruggemann, P.A. Evans, M. Hummel, and F.L. Lavender Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936 Leukemia 17 12 2003 2257 2317
20. G.B. Wisman, E.R. Nijhuis, M.O. Hoque, N. Reesink-Peters, A.J. Koning, and H.H. Volders Assessment of gene promoter hypermethylation for detection of cervical neoplasia Int J Cancer 119 8 2006 1908 1914